By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
1. Gray WA, Cardenas JA, Brodmann M, et al. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System. JACC: Cardiovascular Interventions. 2019;12(23):2375-2384.
2. Geraghty PJ, Adams GL, Schmidt A, Lichtenberg M, Wissgott C, Armstrong EJ, Hertting K, on behalf of the TOBA II BTK Investigators. "Twelve-month results of Tack-optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries (TOBA II BTK)." Journal of Endovascular Therapy 27.4 (2020): 626-636.
Intended use: The Tack endovascular system (4F, 1.5 mm-4.5 mm) is intended for use in mid/ distal popliteal, tibial and peroneal arteries, ranging in diameter from 1.5 mm to 4.5 mm, for the treatment of post percutaneous transluminal balloon angioplasty (PTA) dissection(s). The Tack endovascular system (6F, 3.5-6.0 mm US/ 2.5-6.0 mm EU and 4.0-8.0 mm) is intended for use in the superficial femoral and proximal popliteal arteries ranging in diameter from 3.5 mm to 6.0 mm US/ 2.5 to 6.0 mm EU and 4.0 mm to 8.0 mm for the repair of post percutaneous transluminal balloon angioplasty (PTA) dissection(s).
Contraindications for use: The Tack endovascular system is contraindicated for the following: 1. Patients with residual stenosis in the treated segment equal to or greater than 30% after PTA. 2. Tortuous vascular anatomy significant enough to prevent safe introduction and passage of the device. 3. Patients with a known hypersensitivity to nickel titanium alloy (Nitinol). 4. Patients unable to receive standard medication used for interventional procedures such as anticoagulants, contrast agents and antiplatelet therapy.
Prior to using the Tack endovascular system, please review the instructions for use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.
Tack endovascular system is CE Mark authorized under EC Directive 93/42/EEC.
Tack endovascular system and Tack are registered trademarks of Intact Vascular, Inc. Adaptive sizing is a trademark of Intact Vascular, Inc.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Always read the label and follow the directions for use
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Philips reserves the right to change product specifications without prior notification.
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
